Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOT Diary App for PrEP Adherence in Young Men
NCT03771638Phase 4Completed
- Sponsor
- Heluna Health
- Start
- Feb 2019
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Heluna Health. Primary endpoints: Effect of DOT Diary App on PrEP Adherence at 24 weeks, Concordance of TFV-DP and FTC-TP in DBS With Adherence Measured by DOT Diary App at 24 weeks and 2 more. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03771638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771638.